Cas:298-95-3 Neotetrazolium chloride manufacturer & supplier

Chemical Name:Neotetrazolium chloride

CAS.NO:298-95-3

Synonyms:NTC;6-nitrobenzylalcohol;NEOT;TETRAZOLIUM PURPLE;TETRAZOLE PURPLE;NTMF;NEOTETRAZOLIUM BLUE;neotetrazolium

Molecular Formula:C₃₈H₂₈Cl₂N₈

Molecular Weight:667.58900

HS Code:

Physical and Chemical Properties:

Melting point:230ºC (dec.)(lit.)

Boiling point:754.15°C (rough estimate)

Density:1.0962 (rough estimate)

Index of Refraction:1.6300 (estimate)

PSA:69.18000

Exact Mass:666.18100

LogP:0.41040

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like NTC chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,neotetrazolium physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-nitrobenzylalcohol Use and application,NEOTETRAZOLIUM BLUE technical grade,usp/ep/jp grade.

Related News: The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. Neotetrazolium chloride manufacturer Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing. Neotetrazolium chloride supplier Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees. Neotetrazolium chloride vendor Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday. Neotetrazolium chloride factory The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.